All Featured Insights

The last decade in healthcare has focused on building scale through mergers, diversification and integration. But scale alone does not guarantee coordination, access or performance. In this perspective, Vizient CEO Byron Jobe explains why systemness in healthcare is no longer a strategic preference but an operational imperative.

In 2025, many health system leaders renewed an enterprise-wide strategy while navigating major uncertainties. They evaluated growth, advanced ambulatory and service line efforts, and balanced performance, growth, and transformation. In 2026, health systems will need to clearly define how they’ll transform to fulfill their missions and better serve patients.

The healthcare payment landscape continues to face uncertainty as support grows for additional “site neutrality” in reimbursement, with the policy goal of reducing or eliminating payment differentials between hospital-based outpatient departments (HOPDs) and freestanding physician offices or ambulatory care sites for the same services.

As health systems face growing pressure to lower costs, increase market share and run more efficiently, one thing is clear — the strength of their ambulatory care portfolio is quickly becoming a key differentiator.

By effectively putting strategy into action, hospitals and healthcare systems can thrive amid today’s financial and operational challenges and position themselves to confront the looming threats that are just around the corner.

GLP-1 therapies mark a turning point in healthcare; what began as a diabetes therapy now helps with obesity, sleep apnea and more. Here are three emerging ideas that may represent the next breakthrough that will redefine healthcare.

A recent Vizient benchmarking survey found the top barrier to implementing AI is a lack of clear return on investment. A successful AI strategy must include a clear prioritization framework and a deeper understanding of value.

Multi-year health plan products have the potential to change a lot about how healthcare business models work today.

The challenges that hospitals and health systems currently face are amplifying this complexity, from uncertainty about potential changes to federal healthcare policy—including Medicaid and NIH funding cuts and tariffs—inflation, and ongoing workforce challenges.

Senior healthcare leaders and board members routinely ask us the following two questions.

Assessing the future of healthcare price transparency requires taking a couple of steps back to review its recent history.

The hospital and health system leaders we work with are extremely concerned about the financial impact their organizations may experience from potentially significant Medicaid policy changes, following the recent passage of a budget resolution by the U.S. House of Representatives.